Fool.com
The World's Greatest Investing Community
Results 1 - 6 of 6
The Side Effect of Developing Obesity Drugs
The FDA is fickle when it comes to weight-loss drugs.
These promising picks come from investors with market-beating track records.
Will they pull out of their descent or nosedive into the dirt?
Up, Down, Up. Is This Stock a Home Run or Not?
Weight loss isn't enough for Arena to gain flight.
One biotech was among the top 10 stocks to make a big move up recently.
CAPS players who score 100 points in 100 days have become some of the best investors around.
Results 1 - 6 of 6
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK